IL1B and familial Mediterranean fever: Nevertheless, other treatments have been recognized for FMF treatment, such as interleukin-1 (IL-1) inhibitors (e.g., anakinra, canakinumab), which represent the second-line drugs for patients who have colchicine-resistant FMF or who have an intolerance to colchicine [2,4].